Literature DB >> 23344554

The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.

Liza Shtein1, Lilach Toker, Yuly Bersudsky, R H Belmaker, Galila Agam.   

Abstract

RATIONALE: Lithium has been a standard pharmacological treatment for bipolar disorder over the last 60 years; however, the molecular targets through which lithium exerts its therapeutic effects are still not defined. Attenuation of the phosphatidylinositol signal transduction pathway as a consequence of inhibition of inositol monophosphatase (IMPase) has been proposed as one of the possible mechanisms for lithium-induced mood stabilization.
OBJECTIVES: The objective was to study the behavioral effect of the specific competitive IMPase inhibitor L-690,330 in mice in the lithium-sensitive pilocarpine-induced seizures paradigm and the forced swim test (FST).
METHODS: The inhibitor was administered intracerebroventricularly in liposomes.
RESULTS: L-690,330 increased the sensitivity to subconvulsive doses of pilocarpine and decreased immobility time in the FST.
CONCLUSIONS: It is possible that the behavioral effects of lithium in the pilocarpine-induced seizures and in the FST are mediated through the inhibition of IMPase, but reversal of the inhibitor's effect with intracerebroventricular inositol would be an important further step in proof.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344554     DOI: 10.1007/s00213-013-2969-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

Review 1.  Bipolar disorder.

Authors:  R H Belmaker
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

Review 2.  Neural and developmental actions of lithium: a unifying hypothesis.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

3.  Distribution and properties of CDP-diglyceride:inositol transferase from brain.

Authors:  J A Benjamins; B W Agranoff
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

4.  In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330.

Authors:  J R Atack; S M Cook; A P Watt; S R Fletcher; C I Ragan
Journal:  J Neurochem       Date:  1993-02       Impact factor: 5.372

5.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

6.  Lithium stimulates accumulation of second-messenger inositol 1,4,5-trisphosphate and other inositol phosphates in mouse pancreatic minilobules without inositol supplementation.

Authors:  J F Dixon; L E Hokin
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

7.  Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.

Authors:  W A Turski; E A Cavalheiro; M Schwarz; S J Czuczwar; Z Kleinrok; L Turski
Journal:  Behav Brain Res       Date:  1983-09       Impact factor: 3.332

Review 8.  Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients.

Authors:  R H Belmaker; G Agam; D van Calker; M H Richards; O Kofman
Journal:  Neuropsychopharmacology       Date:  1998-09       Impact factor: 7.853

Review 9.  Lithium-pilocarpine seizures as a model for lithium action in mania.

Authors:  R H Belmaker; Yuly Bersudsky
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

10.  Responses to cortical injury: I. Methodology and local effects of contusions in the rat.

Authors:  D M Feeney; M G Boyeson; R T Linn; H M Murray; W G Dail
Journal:  Brain Res       Date:  1981-04-27       Impact factor: 3.252

View more
  2 in total

1.  Ebselen has lithium-like effects on central 5-HT2A receptor function.

Authors:  I Antoniadou; M Kouskou; T Arsiwala; N Singh; S R Vasudevan; T Fowler; E Cadirci; G C Churchill; T Sharp
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

Review 2.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.